Manjunatha Goud

Dr. Manjunatha Goud


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2025 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
RERana A. Elbeshbeishy
Rana A. Elbeshbeishy
RSRasha Aziz Attia Salama
Rasha Aziz Attia Salama
MGManjunatha Goud
Manjunatha Goud
RBRasha Babiker
Rasha Babiker
JMJhancy Malay
Jhancy Malay
TMTarig Hakim Merghani
Tarig Hakim Merghani
Background: Cadaveric dissection has long been a cornerstone of anatomy education, offering unparalleled hands-on experience that fosters both intellectual and emotional growth in medical students. It plays a crucial role in shaping professional identity while enhancing anatomical understanding. However, the emergence of digital platforms, including virtual reality (VR), augmented reality (AR), and 3D modeling, presents new opportunities to transform anatomy education. Objectives: This study explores the perceptions of medical and health sciences students at Ras Al Khaimah Medical and Health Sciences University (RAKMHSU) regarding the integration of digital tools alongside traditional cadaveric dissection. By comparing attitudes toward these approaches, the study aims to identify strategies like using 3D models, animations, and interactive apps to familiarize students with anatomical structures before entering the dissection lab for harmonizing traditional and digital learning methods to optimize anatomy education. Methods: This cross-sectional study was conducted over seven months using an anonymous, structured 20-item questionnaire administered to 454 students from various health disciplines at Ras Al Khaimah Medical and Health Sciences University. A convenience sampling method was used. The questionnaire assessed sociodemographic data, attitudes toward cadaveric dissection, its significance in practical learning, comparisons with digital resources, and its role in professional development. Institutional approval was obtained, and informed written consent was secured from all participants before the study commenced. Results: Medical students expressed significantly stronger support for cadaveric dissection compared to allied health students, particularly regarding emotional engagement (p < 0.05), perceived educational value (p < 0.001), and comfort with handling cadavers (p < 0.001). While both groups acknowledged the benefits of digital resources, medical students reported greater improvements in visualization, confidence, and interactive learning (p < 0.01). Conclusion: Cadaveric dissection remains an essential pillar of anatomy education, offering irreplaceable benefits in anatomical comprehension and psychomotor skill development. This study highlights its role in fostering professional attributes while demonstrating that digital platforms serve as valuable complementary tools. Rather than replacing cadaveric dissection, these digital innovations enhance learning by creating a synergistic educational environment.

25 September 2025 in Children
Verified
Journal Article
Open access
PDF file
Subhranshu Sekhar KarSubhranshu Sekhar Kar
Subhranshu Sekhar Kar
Rajani DubeRajani Dube
Rajani Dube
MGManjunatha Goud
Manjunatha Goud
QGQonitah Gibrata
Qonitah Gibrata
AEAdlen Adnan El-Balbissi
Adlen Adnan El-Balbissi
RFRand Nedal Mohammad Al Khaled Fatayerji
Rand Nedal Mohammad Al Khaled Fatayerji
Background: Children today are growing up in a digital environment where screen-based technology is a central part of everyday life. While screens can offer educational and recreational benefits, there is growing concern about their influence on different areas of child development. Objective: This review explored how screen time affects developmental outcomes in children and adolescents aged 0 to 18 years, focusing on physical, cognitive, emotional, and social domains. Methods: A structured search was carried out across databases such as PubMed, Scopus, Web of Science and PsycINFO to identify relevant studies published between 2014 and 2024. Studies were included if they examined the relationship between screen time and at least one area of child development, involved participants within the target age group, and were peer-reviewed and published in English. The review followed PRISMA guidelines, and articles were independently screened and evaluated for quality by two reviewers. Results: A total of 46 studies met the inclusion criteria. Overall, the evidence points to a link between higher levels of screen use and negative outcomes such as reduced physical activity, poorer sleep, attention difficulties, and challenges in emotional and social functioning. However, some studies indicated that limited or educational screen use, especially with parental involvement, may have neutral or even positive effects in certain contexts. Conclusions: Screen time can have both positive and negative effects on child development, depending on factors like duration, type of content, and the context in which screens are used. Managing screen use through age-appropriate guidelines and adult supervision may help reduce risks and promote healthier development. More longitudinal research is needed to establish clearer recommendations for screen use in childhood.

GBGulam saidunnisa Begum
Gulam saidunnisa Begum
NANoor Alhuda Al-Mashaikhi
Noor Alhuda Al-Mashaikhi
MBMaryam yousuf Said AL Balushi
Maryam yousuf Said AL Balushi
HAHajar Mohammed Alsalehi
Hajar Mohammed Alsalehi
RARayan Salih Alazawi
Rayan Salih Alazawi
Rajani DubeRajani Dube
Rajani Dube
Introduction: PCOS, a common hormonal disorder in women of reproductive age, affects fertility and increases the risks of other diseases. Early detection, risk factor assessment, and intervention are crucial to prevent long-term complications. Materials and Methods: This study was conducted using a pre-validated questionnaire at two medical colleges in the UAE and Oman. The first study (UAE) results are already published. Here, we present the findings of the second study (Oman) and compare them. Results and Discussion: The prevalence of PCOS was 4.6% (n = 7) in Oman and 27.6% (n = 69) in the UAE using the NIH criteria. The most common symptoms were irregular periods, acne, and thinning of hair. Students showed acne as the most prevalent symptom of clinical hyperandrogenism. Omani students showed significantly more acne [70.1% (n = 108) vs. 41.6% (n = 104)], while Emirati students showed a higher prevalence of hirsutism [32% (n = 80) vs. 23.3% (n = 36)]. A higher number of students had irregular periods 30.8% (77/150) in the UAE, although the difference was not statistically significant. The prevalence of PCOS was significantly higher in Emirati medical students than in Omani students (p < 0.05). The prevalence was also lower among medical students in Oman compared to an unselected population, reported by a study that included all consecutive women between 12 and 45 years of age attending a hospital. An increased trend in unhealthy lifestyle practices was observed in the recent study. Obesity was a strong predictor of PCOS symptoms across the populations in both countries (p < 0.05). Conclusion: The prevalence of PCOS and clinical signs of hyperandrogenism vary significantly between countries in the MENA region. There is a need to identify specific risk factors associated with PCOS in different populations, explore the genetic basis, and undertake collaborative efforts among healthcare professionals from various disciplines to raise awareness about PCOS and its associated risks.

1 January 2025 in Advances in Pharmacological and Pharmaceutical Sciences
Verified
Journal Article
Open access
MHMd Sadique Hussain
Md Sadique Hussain
PMPrince Ahad Mir
Prince Ahad Mir
NKNishant Kumar
Nishant Kumar
RMRoohi Mohi-ud-din
Roohi Mohi-ud-din
AWAdil Farooq Wali
Adil Farooq Wali
Mohamed El-TananiMohamed El-Tanani
Mohamed El-Tanani
Drug repurposing, the process of identifying new therapeutic uses for existing drugs, has emerged as a cost‐effective and time‐saving alternative to traditional drug development. This strategy leverages the known pharmacological and safety profiles of approved or investigational drugs to accelerate their clinical application for other diseases. In recent years, repurposed drugs have played a crucial role in addressing treatment gaps in complex and multifactorial diseases such as cancer, neurodegenerative disorders and infectious diseases. This review highlights prominent examples where repurposed drugs have successfully transitioned from laboratory findings to clinical application. We discuss key molecular mechanisms, including polypharmacology and target pathway modulation that enable repositioning. Emphasis is also placed on advances in computational approaches, network pharmacology and data‐driven tools that enhance repurposing efforts. Additionally, we outline the challenges related to regulatory hurdles, intellectual property and clinical validation. By analysing these success stories, we aim to provide a strategic framework to guide future drug repurposing initiatives.

6 February 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Rajani DubeRajani Dube
Rajani Dube
Subhranshu Sekhar KarSubhranshu Sekhar Kar
Subhranshu Sekhar Kar
SBShadha Nasser Bahutair
Shadha Nasser Bahutair
MGManjunatha Goud
Manjunatha Goud
SSShehla Shafi
Shehla Shafi
OBOmnia Babikir
Omnia Babikir
Caffeine is commonly used to excess by the general public, and most pregnant women drink caffeine on a daily basis, which can become a habit. Maternal caffeine intake during pregnancy is associated with severe gestational outcomes. Due to its lipophilic nature, caffeine can cross the blood–brain barrier, placental barrier, and even amniotic fluid. It can be found in substantive amounts in breast milk and semen. There has been a reported drop in neonatal anthropometric measurements with increased caffeine consumption in some cohort studies. This narrative review using literature titles and abstracts from the electronic databases of PubMed, Embase, and Scopus investigates the data linking maternal caffeine use to unfavorable pregnancy outcomes. It also evaluates the validity of the recommendations made by health professionals on caffeine consumption by mothers from the available literature. The results of our comprehensive literature search of case–control studies, cohort studies, randomized control trials, and meta-analyses, imply that caffeine use during pregnancy is linked to miscarriage, stillbirth, low birth weight, and babies that are small for gestational age. It was also found that there may be effects on the neurodevelopment of the child and links to obesity and acute leukemia. These effects can even be seen at doses well below the daily advised limit of 200 mg. The genetic variations in caffeine metabolism and epigenetic changes may play a role in the differential response to caffeine doses. It is crucial that women obtain solid, evidence-based guidance regarding the possible risks associated with caffeine.

Verified
Journal Article
Open access
PDF file
SBShadha Nasser Bahutair
Shadha Nasser Bahutair
Rajani DubeRajani Dube
Rajani Dube
MGManjunatha Goud
Manjunatha Goud
RSRasha Aziz Attia Salama
Rasha Aziz Attia Salama
MPMohamed Anas Patni
Mohamed Anas Patni
RKRakhee Kar
Rakhee Kar
Gestational trophoblastic diseases (GTDs) encompass a spectrum of conditions characterized by abnormal trophoblastic cell growth, ranging from benign molar pregnancies to malignant trophoblastic neoplasms. This systematic review explores the molecular underpinnings of GTDs, focusing on genetic and epigenetic factors that influence disease progression and clinical outcomes. Based on 71 studies identified through systematic search and selection criteria, key findings include dysregulations in tumor suppressor genes such as p53, aberrant apoptotic pathways involving BCL-2 (B-cell lymphoma), and altered expression of growth factor receptors and microRNAs (micro-ribose nucleic acid). These molecular alterations not only differentiate molar pregnancies from normal placental development but also contribute to their clinical behavior, from benign moles to potentially malignant forms. The review synthesizes insights from immunohistochemical studies and molecular analyses to provide a comprehensive understanding of GTD pathogenesis and implications for personalized care strategies.